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cate a negative regulatory role for TCPTP in cytokine
signaling and provide insight into the molecular defect
underlying the phenotype of TCPTP-deficient animals.
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Cytokines mediate a diverse array of physiological ef-2 The Arthur and Sonia Labatt
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such as lymphocyte and monocyte activation to lacta-The Hospital for Sick Children
tion and growth hormone responses. Cytokine receptorsToronto, Ontario M5G 1X8
propagate signaling through recruitment of the Janus3 The Ontario Cancer Institute
family of cytoplasmic tyrosine kinases (JAKs), which areToronto, Ontario M5G 2M9
responsible for the propagation of signaling initiated by4 Department of Laboratory Medicine
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JAKs results in tyrosine phosphorylation of a number ofUniversity of Toronto
signaling molecules, including members of the STATToronto, Ontario M5G 2M9
family of transcription factors [2]. Deregulation of cyto-5 Department of Medical Biophysics
kine function can have dramatic consequences, as ex-University of Toronto
emplified by the generation of gene-targeted mice ofToronto, Ontario M5G 2M9
JAK family members. JAK1-deficient mice die perina-Canada
tally and are unable to nurse [3], while JAK2 gene-tar-
geted mice display embryonic lethality due to anemia
[4, 5]. TYK2 gene-targeted animals display defects inSummary
interferon (IFN)-/ and - signaling as well as interleu-
kin (IL)-12 responses [6, 7]. Finally, JAK3-deficient ani-Background: The immune response is regulated
mals have a phenotype similar to human severe com-through a tightly controlled cytokine network. The coun-
bined immunodeficiency (SCID), due to the lack ofteracting balance between protein tyrosine kinase (PTK)
developed lymphocytes [8, 9]. These genetic studiesand protein tyrosine phosphatase (PTP) activity regu-
have demonstrated the critical and nonredundant rolelates intracellular signaling in the immune system initi-
that cytokine signaling and JAK tyrosine kinases playated by these extracellular polypeptides. Mice deficient
in both the development and function of the immunefor the T cell protein tyrosine phosphatase (TCPTP) dis-
response; however, the regulation of JAK activity re-play gross defects in the hematopoietic compartment,
mains poorly understood.indicating a critical role for TCPTP in the regulation of
Protein tyrosine phosphatases (PTPs) form a largeimmune homeostasis. To date, the molecular basis un-
superfamily of enzymes that play diverse roles in regulat-derlying this phenotype has not been reported.
ing cellular signaling events and homeostasis [10]. All
members of this family are characterized by the pres-
Results: We have identified two members of the Janus
ence of a 240 amino acid PTP domain. The T cell protein
family of tyrosine kinases (JAKs), JAK1 and JAK3, as
tyrosine phosphatase (TCPTP) is a member of this family
bona fide substrates of TCPTP. Inherent substrate spec-
of enzymes predominantly expressed in the hematopoi-
ificity in the TCPTP-JAK interaction is demonstrated by
etic lineage [11]. TCPTP null mice display severe defects
the inability of other closely related PTP family members
in the hematopoietic compartment, resulting in death
to form an in vivo interaction with the JAKs in hematopoi-
from anemia at 3–5 weeks of age [12]. These animals
etic cells. In keeping with a negative regulatory role for
suffer from runting, splenomegaly, lymphadenopathy,
TCPTP in cytokine signaling, expression of TCPTP in
as well as defects in lymphocyte proliferation and hema-
T cells abrogated phosphorylation of STAT5 following
topoiesis, all of which are phenotypic characteristics
interleukin (IL)-2 stimulation. TCPTP-deficient lympho-
that are in accordance with a defect in cytokine signal-
cytes treated with IL-2 had increased levels of tyrosine-
ing. This pleiotropic phenotype observed in TCPTP-defi-
phosphorylated STAT5, and thymocytes treated with
cient mice led us to investigate the function of TCPTP
interferon (IFN)- or IFN- had increased tyrosine-phos-
in cytokine signaling.
phorylated STAT1. Hyperphosphorylation of JAK1 and
Substrate identification is a crucial step in delineating
elevated expression of iNOS was observed in IFN--
the signaling pathways regulated by PTPs in vivo. To
treated, TCPTP-deficient, bone marrow-derived macro-
attain this goal, a substrate-based trapping approach
phages.
can be employed to identify physiological targets of
PTPs [13]. Catalytic domain mutants of PTPs can be
Conclusions: We have identified JAK1 and JAK3 as generated by mutation of the aspartic acid residue,
physiological substrates of TCPTP. These results indi- which acts as a general acid in the phosphate ester
hydrolysis reaction. This mutation ablates the ability of
PTPs to dephosphorylate target substrates but leaves6 Correspondence: jmcglade@sickkids.on.ca
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Figure 1. TCPTP Binds JAK1 and JAK3 in Cy-
tokine-Stimulated Cells
(A) CTLL-2 cells were transfected with
TCPTP-WT or -DA, cytokine depleted, and
stimulated with IL-2 for 15 min. TCPTP immu-
noprecipitates were blotted with anti-phos-
photyrosine antibodies to identify coimmuno-
precipitating substrates. Membranes were
stripped and reprobed with antibodies to
JAK1, JAK3, and phospho-JAK1 (pY1022/
1023). All experiments were blotted for
TCPTP to ensure equal immunoprecipitation
of the PTP.
(B) 293T cells were transfected with TCPTP-
WT or -DA and stimulated for 15 min with
IFN-. TCPTP immunoprecipitates were blot-
ted with anti-phosphotyrosine and antibodies
to identify coimmunoprecipitating sub-
strates. Membranes were stripped and re-
probed with antibodies against JAK1 and
JAK2, and TCPTP to ensure equivalent ex-
pression of TCPTP.
substrate binding intact. Therefore, PTP-substrate com- Furthermore, the recent structural analysis of the highly
related phosphatase PTP1B suggests that the preferredplexes can be isolated by coimmunoprecipitation, and
the substrates can subsequently be identified. Here, we substrates of both TCPTP and PTP1B likely contain a
tandem tyrosine motif such as that found in the activa-use an in vivo substrate-trapping approach to identify
substrates of TCPTP. tion loop of the JAK family of tyrosine kinases [14]. Since
TCPTP is abundantly expressed in multiple hematopoi-
etic cell types, and a significant fraction of the proteinResults
resides in the cytoplasm in hematopoietic cells (see
Figure S1 in the Supplementary Material available withJAK1 and JAK3 Are Substrates of TCPTP
The phenotype of TCPTP-deficient mice is consistent this article online), we asked whether JAK family mem-
bers are substrates for TCPTP. We constructed eitherwith a role for TCPTP in regulating cytokine signaling.
Figure 2. The Interaction of TCPTP and the
JAKs Is Specific for the PTP Domain of
TCPTP
(A) CTLL-2 cells were transfected with DA-
trapping mutants for TCPTP, PTP-PEST, and
PTP1B. IL-2-stimulated cells were processed
for immunoprecipitation of the PTPs, and pu-
tative substrates were revealed by SDS-
PAGE and anti-phosphotyrosine immuno-
blotting.
(B) CTLL-2 cells transfected with TCPTP-DA
and stimulated with IL-2 in the presence or
absence of 2 mM sodium orthovanadate, a
potent competitive inhibitor of PTPs.
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wild-type (WT) or D182A (DA) substrate-trapping mu-
tants of TCPTP to isolate potential substrates by coim-
munoprecipitation in vivo. In preliminary experiments,
cotransfection of TCPTP-DA with JAK1, JAK2, JAK3,
and TYK2, followed by immunoprecipitation of TCPTP
and anti-phosphotyrosine blotting, indicated that
TCPTP does bind to JAK family members (see Figure
S2 in the Supplementary Material available with this
article online).
To investigate the role of TCPTP in endogenous cyto-
kine signaling, CTLL-2 cells, a cytotoxic T cell line de-
pendent on IL-2 for growth, were transfected with
TCPTP-WT, TCPTP-DA, or empty vector and stimulated
with IL-2 to activate the IL-2 receptor as well as the
downstream effectors JAK1 and JAK3. Putative sub-
strates were revealed by immunoprecipitation of TCPTP
and anti-phosphotyrosine immunoblotting to detect ty-
rosine-phosphorylated proteins bound by the TCPTP-
DA-trapping mutant. In CTLL-2 cells stimulated with
IL-2, two coimmunoprecipitating substrates were re-
vealed by anti-phosphotyrosine immunoblotting (Figure
1A). Selective coimmunoprecipitation of these two sub-
strates, from the numerous phosphoproteins present
in the IL-2-stimulated lysates of these cells, indicates
specificity in substrate recognition by TCPTP. Based
upon the molecular weight of the coimmunoprecipitat-
ing bands and the observed inducible tyrosine phos-
phorylation of these proteins following IL-2 stimulation,
we reasoned that these putative substrates might in-
deed be JAK1 and JAK3, both of which are activated
Figure 3. The Activation Loop of JAK1 Is the Molecular Target of
after IL-2 receptor engagement. Reprobing of the blot TCPTP
from this experiment with anti-JAK1 and anti-JAK3 anti- (A) TCPTP dephosphorylates both JAK1 and JAK3 in vivo. HA-
bodies and anti-phospho-JAK1, which recognizes both tagged JAK1 or JAK3 were cotransfected with TCPTP-WT or
activated JAK1 and JAK3, identified both JAK1 and TCPTP-DA in COS7 cells. The JAKs were immunoprecipitated with
anti-HA followed by anti-phosphotyrosine immunoblotting to deter-JAK3 as inducibly coimmunoprecipitating with the
mine the effect of TCPTP-WT or -DA on JAK phosphorylation levels.TCPTP-DA substrate-trapping mutant (Figure 1A).
The bottom panel shows that both TCPTP-WT and -DA were equallyTo examine the role of TCPTP in a distinct cytokine
expressed.
signaling pathway, we transfected human 293T cells (B) JAK1 and either TCPTP-WT or -DA were cotransfected, and
with TCPTP-WT, TCPTP-DA, or empty vector. Following lysates, as in (A), were incubated with a pY1022/1023 phospho-
treatment with IFN-, which signals through JAK1 and specific JAK1 antibody that detects the tandem activation loop pho-
sphotyrosines (Biosource).JAK2, a single phosphotyrosine-containing protein was
(C) Primary amino acid sequence comparison of the tandem tyrosinecoimmunoprecipitated with TCPTP-DA. Subsequent
residues found in all four JAK family members and the putativeWestern blotting identified this band as JAK1 (Figure
PTP1B/TCPTP consensus substrate recognition motif.
1B). Notably, JAK2 was not coprecipitated with TCPTP,
although it is activated downstream of IFN-.
and JAK3 is mediated via the catalytic domain, we per-
formed an IL-2-stimulated coimmunoprecipitation from
transfected CTLL-2 cells in the presence or absenceSpecificity of the TCPTP-JAK Interaction
To determine whether the interaction of TCPTP with of 2 mM sodium orthovanadate, a potent competitive
inhibitor of PTPs. In the presence of this inhibitor, allJAK1 and JAK3 is specific, or whether they are general
substrates of other PTP family members, CTLL-2 cells binding of phosphotyrosine proteins to TCPTP-DA was
abolished, implicating the PTP domain as the mediatorwere transfected with DA substrate-trapping mutants
of PTP-PEST, a member of the PEST family of PTPs of the TCPTP-JAK interaction (Figure 2B).
We next tested whether JAK1 and JAK3, as putativeknown to play a role downstream of antigen receptors
[15]; PTP1B, a PTP that shares 74% sequence identity substrates of TCPTP, are efficiently dephosphorylated
in vivo. Cotransfection of JAK1 or JAK3 with TCPTP-WTwith TCPTP within the catalytic domain; or TCPTP. Fol-
lowing IL-2 stimulation, only TCPTP-DA formed a sub- resulted in substantial dephosphorylation of the kinases,
while TCPTP-DA protected both JAKs from dephos-strate-trapping complex with JAK1 and JAK3, while nei-
ther PTP-PEST nor PTP1B bound these putative phorylation (Figure 3A).
Recent structural and kinetic data describing the cata-substrates in vivo; although, PTP1B-DA did coimmuno-
precipitate a distinct set of phosphotyrosyl proteins (Fig- lytic domain interaction of PTP1B, a close relative of
TCPTP, complexed to the insulin receptor kinase activa-ure 2A, and data not shown).
To assess whether the interaction of TCPTP with JAK1 tion loop phosphotyrosines, has been reported [14]. Ki-
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Figure 4. TCPTP Regulates Signaling Events
Downstream of the IL-2 Receptor
(A) Cotransfection of Myc-STAT5a and
TCPTP-WT or -DA in CTLL-2 cells, followed
by IL-2 stimulation and immunoprecipitation
of the Myc-tagged STAT5a, was performed to
assess the effect of TCPTP on IL-2-induced
STAT5 tyrosine phosphorylation with phos-
pho-specific antibodies.
(B) Peripheral T cells from lymph node were
isolated from wild-type (WT) and TCPTP null
mice (KO) and stimulated with 1000 U/ml IL-2
for 15 min. Cell lysates were resolved by SDS-
PAGE, and immunoblotting was performed
with phosphotyrosine-specific STAT5 anti-
bodies. The membrane was reprobed for
STAT5 to assess loading of the STAT5 protein
and with antibodies to TCPTP to verify the
genotype of the cells used in the experiment.
(C) A graphic representation of STAT5 tyro-
sine phosphorylation levels obtained from IL-
2-stimulated T cells from wild-type (/) or
TCPTP-deficient mice (/) as shown in part
(B) and quantified by densitometry. Shown is
the mean of three independent experi-
ments  standard deviation. Data were ana-
lyzed by an unpaired, two-tailed Student’s t
test comparing the results of the wild-type,
set to 100, and the knockout (n 3, p 0.05).
(D) Decreased levels of STAT5 in TCPTP-deficient T cells. Equivalent amounts of total protein lysate from primary T cells were separated by
SDS-PAGE and immunoblotted with anti-STAT5 and anti--tubulin to confirm equivalent amounts of total protein in each sample.
netic evidence supports the structural model in which Myc immunoprecipitates were blotted using a phospho-
tyrosine-specific STAT5 antibody, as an indication ofPTP1B preferentially binds to tandem phosphotyrosine
motifs within polypeptides present in a consensus se- the level of STAT5 activation. In the presence of vector
alone, activation of STAT5 proceeded normally in re-quence of D/E-pYpY-K/R. JAK family members contain
a similar activation loop motif; although, notably, JAK1 sponse to IL-2 (Figure 4A). When cotransfected with
TCPTP-WT, STAT5 activation was impaired, as ob-and JAK3 vary from this consensus and have a T or V
residue, respectively, in place of the basic (K/R) residue, served by the decrease in tyrosine phosphorylation,
while cotransfection of the TCPTP-DA mutant did notcarboxy-terminal to the tandem tyrosines (Figure 3C).
The high homology of the catalytic domains of TCPTP hinder the activation of STAT5. We also examined the
and PTP1B points to these phosphorylation sites as the effect of TCPTP loss of function on STAT5 phosphoryla-
likely molecular target of TCPTP. Using a site-specific tion in primary lymph node-derived T cells from either
antibody directed against the activation loop phospho- wild-type or TCPTP-deficient mice. Following IL-2 stim-
tyrosines in JAK1 (pY1022/pY1023), we found that these ulation of primary T cells, lysates were immunoblotted
sites were in fact dephosphorylated by TCPTP, as the with anti-phospho-STAT5 antibodies. In TCPTP-defi-
phospho-specific anti-JAK1 did not detect JAK1 coex- cient primary T cells, we consistently observed hyper-
pressed with TCPTP-WT (Figure 3B). Dephosphorylation phosphorylation of STAT5 as compared to cells from
of the activation loop tyrosine residues by TCPTP is wild-type control animals (Figures 4B and 4C). These
predicted to decrease JAK kinase activity, and therefore results are consistent with a negative regulatory function
suggests a negative regulatory function for TCPTP in for TCPTP in IL-2 signaling via dephosphorylation of
cytokine signaling. JAK3 and JAK1. TCPTP-deficient T cells also contained
reduced levels of STAT5 protein (Figure 4D), another
indication of deregulated signaling in the absence ofSTAT Phosphorylation Is Regulated by TCPTP
TCPTP.Binding of cytokines to their receptors leads to the acti-
Since we had observed that TCPTP-DA binds JAK1vation of JAKs and subsequent tyrosine phosphoryla-
in IFN--stimulated 293T cells, we also investigated thetion of STAT polypeptides, required for their dimeriza-
consequence of loss of TCPTP activity on STAT1 tyro-tion and translocation to the nucleus where they activate
sine phosphorylation. Primary thymocytes, from bothtarget genes [2]. We investigated the effect of both
wild-type and TCPTP gene-targeted animals, were stim-TCPTP overexpression and loss of function on the
ulated with IFN-. Immunoblotting with a phospho-downstream effector STAT5, in the IL-2 signaling path-
STAT1 antibody revealed an increase in STAT1 phos-way. CTLL-2 cells were cotransfected with a Myc-
phorylation in TCPTP-deficient thymocytes (Figure 5A).tagged STAT5a construct and either TCPTP-WT,
Similarly, increased levels of tyrosine-phosphorylatedTCPTP-DA, or vector alone. The cells were depleted of
cytokine and subsequently stimulated with IL-2. Anti- STAT1 were also found in TCPTP-deficient thymocytes
Current Biology
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on JAK2 phosphorylation levels (Figures 6A and 6C).
These results indicate the substrate selectivity of TCPTP
for JAK1 in vivo. To investigate the functional conse-
quences of JAK1 hyperphosphorylation in the TCPTP-
deficient macrophages, we examined the expression of
iNOS, a primary target of IFN- signaling. Total cell ly-
sates from primary BMDMs, derived from TCPTP-defi-
cient or wild-type littermate controls treated with IFN-,
were immunoblotted with anti-iNOS (Figure 6D). Expres-
sion of iNOS was consistently elevated in TCPTP-defi-
cient macrophages, indicating hyperactivation of the
IFN- signaling pathway.
Discussion
The molecular events that negatively regulate cytokine
signaling pathways remain largely unknown. The SOCS
and PIAS family of proteins, as well as the PTPs SHP-1
and CD45, have been reported to play a role in regulating
cytokine signaling events [16]. SHP-1-deficient mice dis-
play gross hematopoietic abnormalities such as autoim-
munity and macrophage hyperactivation that seem to
indicate a negative role in cytokine signaling [17]. SHP-1
is known to play a well-characterized role in the negative
regulation of antigen receptor signaling, as both T and
B cells from SHP-1-deficient animals are hyperprolifera-
tive in vivo [18]. In SHP-1-deficient mice, hyperphos-
phorylation of JAK1 is observed in interferon signaling
[19], and prolonged phosphorylation of JAK2 is ob-
served after injection of growth hormone [20]. In the
context of erythropoietin receptor signaling, recruitmentFigure 5. Hyperphosphorylation of STAT1 in TCPTP-Deficient Thy-
of SHP-1 to the tyrosine-phosphorylated receptormocytes
chains enables its attenuation of JAK2 activation [21].(A and B) Thymocytes from wild-type (WT) and TCPTP-deficient
A direct catalytic domain interaction of SHP-1 with themice (KO) were stimulated with 1000 U/ml (A) IFN- and (B) IFN -
for 15 min. Activation of STAT1 was assessed with a phosphotyrosine- JAKs has not been demonstrated, thereby leaving some
specific STAT1 antibody. Genotypes of the cells used were confirmed uncertainty as to the molecular mechanism of SHP-1
with anti-TCPTP immunoblotting. The results of two independent and negative regulation of cytokine signaling.
representative experiments using cells derived from two individual
The transmembrane PTP CD45 has recently been im-TCPTP null animals and wild-type littermate controls are shown.
plicated in cytokine signaling and as a regulator of the
JAK family [22]. Mice homozygous for deletions in either
exon-6 [23] or exon-9 [24] show reduced B cell matura-stimulated with IFN- (Figure 5B). These results indicate
that TCPTP negatively regulates a variety of cytokine tion and a marked reduction in positive selection during
thymic development. Antigen receptor-driven signalssignaling pathways in vivo as a consequence of its ac-
tion on JAK1 and JAK3. are defective in both T and B cells, as well as in IgE-
promoted degranulation of mast cells [23, 24]. While
cells from CD45 mutant mice show hyperactivation ofHyperphosphorylation of JAK1 and Elevated
Expression of iNOS in TCPTP-Deficient all JAKs, this study failed to demonstrate a physical
association of the PTP domain with the putative sub-Macrophages
In order to obtain sufficient material to directly examine strates in vivo as well [22]. CD45 may play a discrete
role in cytokine signaling, but the phenotype of CD45-JAK phosphorylation status in the TCPTP null mice, as
well as investigate the role of TCPTP in additional down- deficient animals suggests that antigen receptor signal-
ing is most sensitive to the loss of this PTP and otherstream events, we cultured bone marrow-derived mac-
rophages (BMDMs) from both wild-type and knockout PTPs are present to regulate cytokine signaling.
In this report, we have demonstrated a functional in-animals. BMDMs were stimulated with IFN-, a potent
activator of macrophages, and both JAK1 and JAK2 teraction of the catalytic domain of TCPTP with mem-
bers of the JAK family of tyrosine kinases. Our resultswere immunoprecipitated from cell extracts. Anti-phos-
photyrosine immunoblotting of JAK1 immunoprecipi- indicate that both JAK1 and JAK3 are specific TCPTP
substrates. It is interesting to note that TCPTP may tar-tates revealed that the loss of TCPTP resulted in a signifi-
cant increase in the tyrosine phosphorylation of JAK1 get certain members of the JAK family depending on
the cytokine signaling pathway in question. We havecompared to wild-type control BMDM (Figures 6A and
6B). Consistent with the results in Figure 1B, anti-phos- observed a preferential interaction of TCPTP-trapping
mutants with both JAK1 and JAK3 downstream of thephotyrosine immunoblotting of JAK2 immunoprecipi-
tates revealed that loss of TCPTP had no apparent effect IL-2 receptor. In BMDMs from TCPTP-deficient mice,
JAK1 and JAK3 Are Substrates of TCPTP
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Figure 6. Primary Macrophages from TCPTP
Null Mice Have Hyperphosphorylated JAK1
and Elevated Expression of iNOS
(A) BMDMs from wild-type (WT) and TCPTP
null mice (KO) were cultured and stimulated
with 1000 U/ml IFN- for 15 min. Cells were
lysed, and JAK1 and JAK2 were immuno-
precipitated and subjected to anti-phospho-
tyrosine immunoblotting. Membranes were
stripped and reprobed with anti-JAK1 or anti-
JAK2 to confirm equivalent immunoprecipita-
tion. Lysates were immunoblotted for TCPTP
to confirm the genotype.
(B and C) A graphic representation of (B) JAK1
(C) and JAK2 tyrosine phosphorylation from
IFN--stimulated BMDMs from wild-type
(/) or TCPTP-deficient mice (/) as
shown in part (A) and quantified by densitom-
etry. Shown is the mean of three independent
experiments standard deviation. Data were
analyzed by an unpaired, two-tailed Student’s
t test comparing the results of the wild-type,
set to 100, and the knockout (n  3, p  0.1).
(D) BMDMs from wild-type (WT) or TCPTP-
deficient (KO) mice were stimulated with 100
U/ml IFN- for 20 hr. Total cell lysates were Western blotted with anti-iNOS. The results from two independent experiments, with cells derived
from individual TCPTP wild-type and -deficient littermate controls, are shown.
JAK1 phosphorylation levels are increased after IFN- substrate-trapping approach and biochemical analysis
of primary cells from TCPTP gene-targeted mice. Thesestimulation, while JAK2 phosphorylation appears to be
unaffected. While we cannot preclude a role for TCPTP results indicate a fundamental role for TCPTP in cytokine
signaling that correlates well with the observed pheno-in regulating phosphorylation of JAK2 and TYK2, the in
vivo analysis of both cultured cell lines and primary type of the knockout animals and describes a novel
mechanism in the regulation of the immune response.hematopoietic cells suggests that TCPTP does not have
a general effect on all of the JAK family members.
Experimental ProceduresDue to the high similarity within the respective cata-
lytic domains of TCPTP and PTP1B, they were predicted
Materialsto target similar substrates [14]. Recently, it has been
Unless otherwise specified, all materials were obtained from Sigma.demonstrated that JAK2 and TYK2 are substrates of
RPMI, DMEM, and fetal bovine serum (FBS) were obtained from
PTP1B in fibroblasts [25]. It is interesting to note that, Wisent; recombinant murine IL-2 was obtained from Roche, while
although both TCPTP and PTP1B appear to regulate recombinant murine IFN-, murine IFN-, and recombinant human
M-CSF were obtained from Calbiochem; and human IFN- wasmembers of the JAK family, the phenotypes of PTP1B
obtained from GIBCO. Antibody 4G10 against phosphotyrosine;and TCPTP-deficient mice are strikingly different [12,
anti-JAK1, anti-JAK2, and anti-JAK3 antisera; and anti-iNOS and26, 27]. PTP1B gene-targeted mice are resistant to diet-
anti-PARP antibodies were obtained from Upstate Biotechnology.induced obesity and diabetes, while TCPTP-deficient
Anti-TCPTP antibodies 3E2 and 6F3 were purified from tissue culture
mice display hematopoietic abnormalities. Our results, supernatants of the respective hybridomas. Monoclonal antibodies
and previous reports, indicate that other factors, which anti-JAK1 and anti-TYK2 were obtained from BD Transduction Lab-
oratories. All PCR reactions were performed using vent DNA poly-may include tissue-specific expression patterns, sub-
merase (New England Biolabs) with primers synthesized by ACGT.cellular localization [28], and additional higher order in-
Complete protease inhibitor tablets were obtained from Roche.teractions, are involved in substrate recognition and the
observed differences in substrate specificity.
Cell CultureThese findings provide insight into the biochemical
CTLL-2 cells were routinely cultured in RPMI supplemented withbasis for the phenotype observed in the TCPTP-defi- 10% (v/v) FBS, 5 U/ml penicillin, 5 mg/ml streptomycin sulfate, 55
cient mice. T cell secretion of IFN- during the immune 	M 2-mercaptoethanol (GIBCO-BRL), and 2 U/ml IL-2 at 37
C with
response is known to play an important role in macro- 5% CO2. COS-7 and 293T cells were cultured in DMEM containing
10% (v/v) FBS, 5 U/ml penicillin, and 5 mg/ml streptomycin sulfate.phage activation. Hypersensitivity of macrophages to
IFN- would result in their hyperactivation and lead to
Plasmids and Mutagenesisthe overproduction of inflammatory cytokines such as
All wild-type or mutant cDNAs were placed in the pEF-BOS expres-TNF- and IL-1. Indeed, increased numbers of activated
sion vector (a kind gift Dr. Gary Koretzky, University of Pennsylvania)macrophages are observed in the spleen of TCPTP-
in the 5-ClaI/XbaI-3 sites. C-terminal Myc tags were introduced
deficient mice, which is consistent with an acute inflam- by including the epitope tag sequence in the antisense primer for
matory response [11]. PCR. The TCPTP-D182A mutant was constructed using PCR with
the following mutagenic primers (mutation underlined): () 5-
TGAAACGAGAACCATATCTCAC-3, () 5-CTGGAACCCCAAAAGC
Conclusions TGGCC-3; and the following terminal primers: ()5-TAAATCGATC
In this report, we have identified JAK1 and JAK3 as CACCATGTCGGCAACCATCG-3, () 5-GTGTCTAGATTAGGTGT
CTGTCAATCTTGG-3. The same terminal primers were used forphysiological substrates of TCPTP via a tandem in vivo
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pEF-TCPTP-WT. The PTP-PEST-WT cDNA was subcloned into the in HNMETG buffer containing 10 mM NaF, 2 mM Na3VO4, and 420
mM NaCl to extract nuclear components. Lysates were resolved bypEF-BOS vector at the 5-ClaI/XbaI-3 sites. The PTP-PEST-D199A
mutant was created with the following primers: () 5-GAATCGATT SDS-PAGE and immunoblotted with anti-phospho-specific STAT1
or STAT5 antibodies. Data were analyzed by densitometry with theGGAGGATGGAGCAAGTGGAG-3, () 5-GTGAACTGGCCAGCC
CATGATG-3, () 5-GTGGTACCTGTCACTGTCCTG-3, and () 5- wild-type value set to 100 in each experiment. Bone marrow-derived
macrophages were obtained by flushing the femurs of 14-day-oldCATCATGGGCTGGCCAGTTCAC-3. The resulting PCR product
was cloned into the PTP-PEST cDNA using a 5-ClaI site and an wild-type or TCPTP-deficient mice with DMEM containing 10% FBS
and antibiotics. The cells were pelleted and resuspended in theinternal HindIII site. The PTP1B WT and D181A cDNAs were ampli-
fied with the following primers: () 5-GAGGATCCGAGATGGAAA above medium supplemented with 10 ng/ml M-CSF. Stromal cells
and mature macrophages were removed by adherence to tissueAGGAGTTCG-3 and () 5-GAGCGGCCGCCTATGTGTTGCTGTT
GAACAG-3, and were subcloned into the pEBG vector at the 5- culture plastic for 24 hr. The next day (day 1), nonadherent cells
were resuspended at 1.5–2.0  105/ml M-CSF-containing mediumBamHI/NotI-3 sites. Constructs expressing JAK1, JAK3, and TYK2
were prepared by blunt ending the 5 ends of the cDNAs with the T4 and plated in 100-mm tissue culture plates. At day 4, the medium
was removed and replaced with fresh growth medium containingDNA polymerase (Roche), then digesting with XbaI. These modified
cDNAs were ligated in to a 5-ClaI-blunt ended/XbaI-3-digested M-CSF. At day 7, cells were depleted of M-CSF for 16–18 hr and
stimulated with 1000 U/ml IFN-. For the induction of iNOS, BMDMspEF-BOS vector. The integrity of all constructs was verified by fully
sequencing the cDNA (Hospital for Sick Children, DNA sequencing were incubated with or without 100 U/ml IFN- for 20 hr. Cells were
lysed and subjected to immunopreciptiation and Western blottingfacility).
as described.
Western Blotting
Protein complexes were resolved by 8% or 10% SDS-PAGE and Supplementary Material
transferred to PVDF membranes (Immobilon, Millipore). For phos- Supplementary Material including additional Experimental Proce-
photyrosine, membranes were blocked for 60 min in 1% BSA in dures and two supplementary figures is available at http://images.
TBST. 4G10 was added at 1 	g/ml in blocking buffer for 60 min at cellpress.com/supmat/supmatin.htm.
room temperature. The membranes were washed three times, and
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